Related Experiment Video
Updated: Jul 17, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
[Poor access to antiretroviral treatment in French-speaking Africa: situation in 2004]
C Boisseau1, H Degui, C Bruneton
1ReMeD, Paris, France. remed@remed.org
Abstract:
A survey by questionnaire and interview was carried out with persons in charge of purchasing central structures and AIDS control programs in 18 French-speaking African countries between June and October 2004. Survey data showed that a total of 3300 patients received antiretroviral (ARV) treatment during the study period. This corresponds to a treatment rate of 0.1 to 9.6% of the number of patients requiring ARV treatment. All countries reported interruptions of the ARV supply for a variety of reasons. The main causes were budgetary issues and procedural complexity involving financial aid. The prices charged to the patients varied greatly in function of national policies. Cost price also varied in function of the negotiating leverage of the purchasing central. Improve general access to ARV treatment and reducing the number of supply shortages will require more training in management and distribution of medicines. It would also be useful to improve communications between the persons in charge of national purchasing structures.
Related Concept Videos
Retrovirus Life Cycles
Cryptococcal Meningitis
Pharmacokinetics in Pediatric Patients: Drug Excretion
Retroviruses
Sexually Transmitted Infections

